Common Contracts
3 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • January 26th, 2022
CLINICAL TRIAL AGREEMENT This Clinical Trial Agreement (“Agreement”) is made as of the last date of signature and becomes effective as of the day when Agreement is published in the Contract Register, a public administration information system in which contracts concluded by entities specified in Act No. 340/2015 Coll., as amended (hereinafter the "Effective Date") are published. ") (“Effective Date”) by and among: Labcorp Drug Development Inc., located at 206 Carnegie Center, Princeton, NJ 08540, USA (Tax ID No.: 22-3265977) and its affiliates (“Labcorp” or “CRO”) ; and Fakultní nemocnice Královské Vinohrady, with registered office at Šrobárova 1150/50, 100 34 Praha 10, Czech Republic, Id No.: 00064173, tax Id No.: CZ00064173, represented by Prof. MUDr. Petr Arenberger, DrSc., MBA, FCMA, reference number: KH 45/2021, expense center 51065,(hereinafter referred to as “Institution”) and MUDr. PharmDr. Jan Dvořák, ,workplace: Department of Radiotherapy and Oncology, Fakutlní nemocnice Král
ContractClinical Trial Agreement • January 6th, 2022
CLINICAL TRIAL AGREEMENT This Clinical Trial Agreement (“Agreement”) is made valid as of the last date of signature and effective as of the date of publication hereof in the Contracts Register (“Effective Date”) by and among: Labcorp Drug Development Inc., located at 206 Carnegie Center, Princeton, NJ 08540, USA, Tax ID: 22-3265977 and its affiliates (“Labcorp” or “CRO”) ; and Fakultní nemocnice Olomouc, with registered office at I. P. Pavlova 185/6, 779 00 Olomouc, Czech Republic, Company No..: 00098892, Tax ID No.: CZ00098892, represented by prof. MUDr. Roman Havlík, Ph.D., Director (hereinafter referred to as “Institution”) and , Fakultni nemocnice Olomouc, I.P. Pavlova 185/6, 779 00 Olomouc, Czech republic (hereinafter referred to as “Investigator”) Whereas, Labcorp, Sponsor and Institution and Investigator are hereinafter referred to individually as “Party” and collectively as “Parties”; Whereas, Labcorp is acting in its capacity as a contract research organization as defined in I
ContractClinical Trial Agreement • October 6th, 2021
CLINICAL TRIAL AGREEMENT This Clinical Trial Agreement (“Agreement”) is made as of the last date of signature and becomes effective as of the THE DAY when Agreement is published in theContract Registry, a public administration information system in which contracts concluded by entities specified in Act No. 340/2015 Coll., as amended (hereinafter the "Effective Date") are published. ") (“Effective Date”) by and among: Labcorp Drug Development Inc., located at 206 Carnegie Center, Princeton, NJ 08540, USA, (VAT Nr. 22-3265977)and its affiliates Covance Clinical and Periapproval Services Limited, organ složka, V Parku 2343/24, 148 00 Praha 4, Czech republic, Company ID: 273 70 976, VAT Nr.: CZ27370976 registered in company registry of the Municipal Court in Prague, file A 52158 on address V Parku 2343/24, 148 00 Praha 4, Czech republic, represented by(“Labcorp” or “CRO”) ; and Fakultní nemocnice Královské Vinohrady, with registered office at Šrobárova 1150/50, 100 34 Praha 10, Czech Repub
